Etanercept‐Methotrexate Combination Therapy Initiators Have Greater Adherence and Persistence Than Triple Therapy Initiators With Rheumatoid Arthritis

Abstract

OBJECTIVE To estimate adherence and persistence with etanercept plus methotrexate (ETN-MTX) combination therapy and MTX, hydroxychloroquine, and sulfasalazine triple therapy at 1 year following treatment initiation in adults with rheumatoid arthritis (RA). METHODS This retrospective analysis used data from the Truven Health MarketScan Commercial and… (More)
DOI: 10.1002/acr.22638

Topics

6 Figures and Tables

Cite this paper

@inproceedings{Bonafede2015EtanerceptMethotrexateCT, title={Etanercept‐Methotrexate Combination Therapy Initiators Have Greater Adherence and Persistence Than Triple Therapy Initiators With Rheumatoid Arthritis}, author={Machaon M K Bonafede and Barbara Johnson and Derek H. Tang and Neel Shah and David J. Harrison and David Collier}, booktitle={Arthritis care & research}, year={2015} }